Wednesday, November 18, 2026Wed, Nov 18

Moon: waxing gibbous, 58% litAurora: active

Español

Space, Earth and the natural world, explained.

Yale Review of 51 Studies Finds Supplements Fail to Slow DNA Aging

A Yale analysis of 51 studies found metformin, semaglutide and diet plus exercise lowered epigenetic age. Supplements showed little measurable effect.

Top view of blood sample tubes in a laboratory centrifuge, essential for medical research.
Photo: Pavel Danilyuk / Pexels

Across 51 clinical studies, some prescription drugs and the combination of a healthy diet with exercise lowered biological age as measured by DNA-based blood tests, while the over-the-counter supplements studied showed little measurable effect, Yale researchers reported in Nature Medicine. The team cautions that a lower score on these tests has not been shown to mean a longer or healthier life.

The strongest drops in aging markers came with metformin and semaglutide, drugs used to treat metabolic conditions and manage weight, and with anti-TNF therapies, which block a protein involved in inflammation.

How the Yale team measured aging

The researchers did not run a new trial. They pooled results from 51 existing human studies that tested supplements, medications, lifestyle changes and medical procedures, and compared measurements taken before and after each intervention.

The main tools were epigenetic clocks. These are computer algorithms that read chemical tags called methyl groups attached to DNA in blood cells. The pattern of those tags shifts as people get older, so a clock can estimate a person’s biological age, which may differ from their age in years. In all, the team looked at more than 110 DNA methylation biomarkers, including 16 major epigenetic clocks.

Lead author Raghav Sehgal, an associate research scientist in psychiatry at the Yale School of Medicine, said earlier data were too thin to show these markers respond consistently to treatments. The work was done in the lab of senior author Albert Higgins-Chen, an assistant professor of psychiatry.

Diet, exercise and drugs compared with supplements

The interventions fell into four groups: prescription drugs, lifestyle changes, over-the-counter supplements and medical procedures. Regular exercise paired with a healthy eating plan lowered epigenetic age consistently. The diets in the studies included Mediterranean, low-fat and low-carb plans.

The supplements in the analysis, and some medical procedures, did not produce measurable reductions. The study does not name which supplements were included.

Two other patterns stood out. Newer epigenetic clocks performed better than older ones, and people with a disease tended to show larger shifts in their aging markers than healthy participants.

What is still unclear

The analysis shows associations, and the authors list several open questions. They do not yet know whether the changes were caused by the treatments or by other factors the studies did not account for. They also do not know how fast the changes appear, whether they last after a treatment stops, or which processes in the body drive them.

The biggest unknown is whether a lower epigenetic age reduces the risk of disease or decline later in life. “The true meaning of that change must be fully understood,” Higgins-Chen said. Sehgal said the next step is testing the findings in larger and more diverse groups of people.

Why it matters for aging research

Trials that wait for people to develop age-related diseases can take decades. If these blood markers are eventually validated as predictors of long-term health, Sehgal said, researchers could judge an anti-aging therapy in a few years or even months. Until then, the clocks are a research tool, and the results do not show that any of these drugs extends life. The study is not a recommendation to take any medication or change a diet; questions about personal health belong with a doctor.

Follow-up studies led by Daniel Borrus, Jenel F. Armstrong and Grace Zou are underway. The paper, “Responsiveness of epigenetic aging biomarkers to longevity interventions in humans,” appears in Nature Medicine (DOI: 10.1038/s41591-026-04562-9).

Source: ScienceDaily